CLINICAL STUDY: ENDOTHELIAL FUNCTION
Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease
Soko Setoguchi, MDa,
Masahiro Mohri, MD, PhDa,
Hiroaki Shimokawa, MD, PhDa and
Akira Takeshita, MD, PhDa
a Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
Manuscript received December 6, 2000;
revised manuscript received March 29, 2001,
accepted April 10, 2001.
Reprint requests and correspondence: Dr. Masahiro Mohri, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan mmohri{at}med.kyushu-u.ac.jp
OBJECTIVES
We aimed to determine whether intracoronary supplementation with nitric oxide (NO) synthase co-factor tetrahydrobiopterin (BH4) improves NO-dependent coronary microvascular dilation in patients with coronary risk factors but no significant organic stenosis.
BACKGROUND
Impaired coronary microvascular dilator reserve attributable to endothelial dysfunction plays an important role in the regulation of coronary blood flow (CBF).
METHODS
Fifteen patients were measured for CBF (Doppler-wire and quantitative coronary angiography). Stimulated release of NO in the coronary microcirculation was evaluated by percent increase in CBF (% CBF) at graded doses of intracoronary acetylcholine (1, 3, 10 and 30 µg/min). Measurements were repeated after intracoronary co-infusion of BH4 (4 mg/min) and acetylcholine.
RESULTS
The patients were divided into two groups on the basis of CBF responses to acetylcholine: those with "diminished" (% CBF <300%, n = 8) and "normal" (% CBF >300%, n = 7) flow responses. Tetrahydrobiopterin significantly (p < 0.0001) improved acetylcholine-induced increases in CBF in patients with diminished flow responses, but exerted no effect in those with normal flow responses. Among the 15 studied patients, the magnitude of flow improvement by BH4 was inversely correlated with baseline flow responses (p < 0.02). Microvascular dilator response to direct NO donor (isosorbide dinitrate) was not affected by BH4.
CONCLUSIONS
We demonstrated for the first time that intracoronary BH4 improved acetylcholine-induced microvascular dilator responses in patients with endothelial dysfunction in vivo. Thus, supplementation with BH4 may be a novel therapeutic means to increase NO availability for patients with coronary microvascular disease.
|
Abbreviations and Acronyms
| | BH4 | = tetrahydrobiopterin | | CAD | = coronary artery disease | | CBF | = coronary blood flow | | LCA | = left coronary artery | | NO | = nitric oxide |
|
This article has been cited by other articles:

|
 |

|
 |
 
M Saito, H Okayama, K Nishimura, A Ogimoto, T Ohtsuka, K Inoue, G Hiasa, T Sumimoto, and J Higaki
Possible link between large artery stiffness and coronary flow velocity reserve
Heart,
June 1, 2008;
94(6):
e20 - e20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kondo, T. Ishikawa, K. Yamaguchi, T. Yada, and M. Fujisawa
Oral Administration of Tetrahydrobiopterin Attenuates Testicular Damage by Reducing Nitric Oxide Synthase Activity in a Cryptorchid Mouse Model
J Androl,
March 1, 2008;
29(2):
153 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Worthley, R. S. Kanani, Y.-H. Sun, Y. Sun, D. M. Goodhart, M. J. Curtis, and T. J. Anderson
Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries
Cardiovasc Res,
December 1, 2007;
76(3):
539 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Moens and D. A. Kass
Tetrahydrobiopterin and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2006;
26(11):
2439 - 2444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Cardounel, Y. Xia, and J. L. Zweier
Endogenous Methylarginines Modulate Superoxide as Well as Nitric Oxide Generation from Neuronal Nitric-oxide Synthase: DIFFERENCES IN THE EFFECTS OF MONOMETHYL- AND DIMETHYLARGININES IN THE PRESENCE AND ABSENCE OF TETRAHYDROBIOPTERIN
J. Biol. Chem.,
March 4, 2005;
280(9):
7540 - 7549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kawashima and M. Yokoyama
Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2004;
24(6):
998 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|